论文部分内容阅读
Chlotazol是新的非固醇类抗炎药,并有抗菌、解热作用,毒性低,对机体免疫有良好的调节作用。慢性支气管炎患者常有细胞免疫障碍,需要免疫矫正治疗。现用Chlotazol治疗慢性阻塞性支气管炎,观察102例,分3组:第1组56例,除常规疗法(祛痰剂,支气管解痉剂,氧气疗法,气功疗法,按适应证用抗菌药)外,给Chlotazol 0.1g,tid共14天。第2组18例,除常规疗法,给免疫调节剂核酸钠0.3g,tid共14
Chlotazol is a new non-steroidal anti-inflammatory drug with antibacterial and antipyretic effects, low toxicity and good immunity to body immunity. Chronic bronchitis patients often have cellular immune disorders, the need for immune correction treatment. Treatment of chronic obstructive bronchitis with Chlotazol, 102 cases were observed, divided into 3 groups: Group 1 56 cases, in addition to conventional therapy (expectorant, bronchial spasmodic agent, oxygen therapy, qigong therapy, according to indications with antibacterials) In addition, Chlotazol 0.1g, tid for 14 days. Group 2 18 cases, in addition to conventional therapy, to the immune regulator sodium 0.3g, tid a total of 14